Aclarion (NASDAQ:ACON) Stock Price Up 12.7% – What’s Next?

Aclarion, Inc. (NASDAQ:ACON) rose 12.7% during mid-day trading on Monday . The stock traded as high as $12.03 and last traded at $9.69. Approximately 3,819,795 shares traded hands during trading, an increase of 1,858% from the average daily volume of 195,092 shares. The stock had previously closed at $8.60.

Analyst Ratings Changes

Separately, Weiss Ratings reiterated a “sell (e+)” rating on shares of Aclarion in a report on Wednesday, October 8th. One analyst has rated the stock with a Hold rating and one has assigned a Sell rating to the company’s stock. According to MarketBeat.com, the company presently has a consensus rating of “Reduce” and an average price target of $11,758.50.

Aclarion Stock Up 12.7%

The business has a fifty day moving average price of $7.59 and a two-hundred day moving average price of $7.62.

Aclarion (NASDAQ:ACON) last released its quarterly earnings data on Thursday, August 14th. The company reported ($2.75) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($2.26) by ($0.49). The firm had revenue of $0.02 million for the quarter, compared to analyst estimates of $0.03 million. Aclarion had a negative net margin of 11,238.59% and a negative return on equity of 83.63%. Sell-side analysts forecast that Aclarion, Inc. will post -263.33 earnings per share for the current fiscal year.

About Aclarion

Aclarion, Inc, a healthcare technology company, leverages for Magnetic Resonance Spectroscopy (MRS) in the United States. It develops NOCISCAN Post-Processor suite of software applications comprising NOCICALC that receives the raw un-processed NOCISCAN MRS exam data and post-processes that raw data into final spectra and performs various degenerative pain biomarker; and NOCIGRAM, a clinical decision support software.